Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

X4 Pharmaceuticals Inc. (XFOR)

  • SEC News
  • Aug. 20, 2025, 21:43 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13G - X4 Pharmaceuticals, Inc Filed: 2025-08-20 AccNo: 0000921895-25-002347 Size: 40 KB

Comment Full text

enVVeno Medical Corp (NVNO)

  • Business News
  • Aug. 20, 2025, 21:39 UTC
  • 6
  • 0 comments

BWR Exploration Inc. Enters into an Amalgamation Agreement with Electro Metals and Mining Inc.

Market reaction Comment Full text

enVVeno Medical Corp (NVNO)

  • Business News
  • Aug. 20, 2025, 21:37 UTC
  • 6
  • 0 comments

Northrop Grumman Board Declares Quarterly Dividend

Market reaction Comment Full text

Novo Nordisk (NVO)

  • Business News
  • Aug. 20, 2025, 21:35 UTC
  • 6
  • 0 comments

NVO STOCK: Robbins LLP Reminds NVO Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Novo Nordisk A/S

Market reaction Comment Full text

enVVeno Medical Corp (NVNO)

  • Business News
  • Aug. 20, 2025, 21:34 UTC
  • 6
  • 0 comments

Brazil Potash Executa Acordo Definitivo De Offtake Com Keytrade Fertilizantes Brasil Para ~900.000 Toneladas De Fertilizante

Market reaction Comment Full text

enVVeno Medical Corp (NVNO)

  • Business News
  • Aug. 20, 2025, 21:30 UTC
  • 4
  • 0 comments

Brazil Potash Executes Definitive Offtake Agreement With Keytrade Fertilizantes Brasil for ~900,000 Tons of Fertilizer

Market reaction Comment Full text

enVVeno Medical Corp (NVNO)

  • Business News
  • Aug. 20, 2025, 21:30 UTC
  • 4
  • 0 comments

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of July 2025

Market reaction Comment Full text

NewAmsterdam Pharma (NAMS)

  • SEC News
  • Aug. 20, 2025, 21:28 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13D/A - NewAmsterdam Pharma Co N.V. Filed: 2025-08-20 AccNo: 0001415889-25-022506 Size: 88 KB

Comment Full text

RxSight Inc. (RXST)

  • Business News
  • Aug. 20, 2025, 21:24 UTC
  • 4
  • 0 comments

RXST Stockholders with Large Losses Should Contact Robbins LLP for Information About the RxSight, Inc. Class Action

Market reaction Comment Full text

KalVista Pharmaceuticals Inc (KALV)

  • SEC News
  • Aug. 20, 2025, 21:21 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13D/A - KalVista Pharmaceuticals, Inc. Filed: 2025-08-20 AccNo: 0001415889-25-022500 Size: 33 KB

Comment Full text

ReShape Lifesciences Inc. (RSLS)

  • SEC News
  • Aug. 20, 2025, 21:21 UTC
  • 4
  • 0 comments

New Form 424B5 - Vyome Holdings, Inc Filed: 2025-08-20 AccNo: 0001213900-25-079042 Size: 10 KB

Comment Full text

GlycoMimetics Inc. (GLYC)

  • SEC News
  • Aug. 20, 2025, 21:20 UTC
  • 4
  • 0 comments

New Form SCHEDULE 13G - CRESCENT BIOPHARMA, INC. Filed: 2025-08-20 AccNo: 0001214659-25-012492 Size: 9 KB

Comment Full text

STERIS plc (STE)

  • SEC News
  • Aug. 20, 2025, 21:20 UTC
  • 4
  • 0 comments

New Form 144 - STERIS plc Filed: 2025-08-20 AccNo: 0001921094-25-001006 Size: 4 KB

Comment Full text

Arcutis Biotherapeutics (ARQT)

  • SEC News
  • Aug. 20, 2025, 21:20 UTC
  • 4
  • 0 comments

New Form SCHEDULE 13D/A - Arcutis Biotherapeutics, Inc. Filed: 2025-08-20 AccNo: 0001415889-25-022498 Size: 63 KB

Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • SEC News
  • Aug. 20, 2025, 21:19 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13D/A - Phathom Pharmaceuticals, Inc. Filed: 2025-08-20 AccNo: 0001415889-25-022496 Size: 46 KB

Comment Full text
  • Previous
  • 209
  • 210
  • 211
  • 212
  • 213
  • Next

Search

News categories

  • Technical Exchange News(9943)
  • Event(412)
  • SEC News(168383)
  • FDA Approval(9362)
  • Company Report(721)
  • Business News(112122)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin